| 9809553 |
Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them |
Stefano Chimenti, Christine Courchay, Aimee Dessinges, Bertrand Goument, Marc Konnert +4 more |
2017-11-07 |
| 8557984 |
Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors |
Anne Marie Jeanne Bouillot, Frederic G. Donche, Yann Lamotte, Olivier Mirguet |
2013-10-15 |
| 7241793 |
Phenyloxyalkanonic acid derivatives as hPPAR activators |
Nerina Dodic, Bernard Dumaitre, Michael Sierra |
2007-07-10 |
| 7157479 |
Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor |
— |
2007-01-02 |
| 7141591 |
1,2,4-oxadiazole derivatives as hPPAR alpha agonists |
Kevin G. Liu |
2006-11-28 |
| 6984641 |
Carboline derivatives as PDE5 inhibitors |
Mark W. Orme, Jason Scott Sawyer, Alain Claude-Marie Daugan, Agnes Bombrun, Lisa M. Schultze +2 more |
2006-01-10 |
| 6911542 |
Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
Mark W. Orme, Jason Scott Sawyer, Lisa M. Schultze, Alain Claude-Marie Daugan |
2005-06-28 |
| 6838456 |
Condensed pyridoindole derivatives |
Mark W. Orme, Jason Scott Sawyer, Alain Claude-Marie Daugan, Romain Luc Marie Gosmini |
2005-01-04 |
| 6462047 |
Carboline derivatives as cGMP phosphodiesterase inhibitors |
Agnes Bombrun |
2002-10-08 |
| 6143746 |
Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
Alain Claude-Marie Daugan |
2000-11-07 |
| 5981527 |
Cyclic GMP-specific phosphodiesterase inhibitors |
Alain Claude-Marie Daugan |
1999-11-09 |
| 5545645 |
Heterocyclic derivatives in the treatment of ischaemia and related diseases |
Jean-Claude Pascal, Gary MCCORT, Dominique Blondet |
1996-08-13 |
| 5428037 |
Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
Jean-Claude Pascal, Gary MCCORT, Dominique Blondet |
1995-06-27 |